N. Malavasi

609 total citations
17 papers, 424 citations indexed

About

N. Malavasi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, N. Malavasi has authored 17 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in N. Malavasi's work include Colorectal Cancer Treatments and Studies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Colorectal Cancer Surgical Treatments (4 papers). N. Malavasi is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Colorectal Cancer Surgical Treatments (4 papers). N. Malavasi collaborates with scholars based in Italy and United Kingdom. N. Malavasi's co-authors include Gabriele Luppi, Federica Bertolini, Pierfranco Conté, Carmelo Bengala, S. Zironi, Roberta Depenni, Cristina Dealis, Annalisa Fontana, Cinzia Del Giovane and C. Boni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

N. Malavasi

16 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Malavasi Italy 8 338 306 128 83 45 17 424
Masashi Yahagi Japan 8 299 0.9× 190 0.6× 157 1.2× 101 1.2× 32 0.7× 17 401
Masanori Kotake Japan 11 297 0.9× 174 0.6× 117 0.9× 84 1.0× 26 0.6× 42 421
Linda Evans United Kingdom 6 165 0.5× 216 0.7× 146 1.1× 101 1.2× 14 0.3× 10 372
Fernando Bonadeo Argentina 8 251 0.7× 178 0.6× 80 0.6× 38 0.5× 29 0.6× 10 302
D. Mari Italy 9 256 0.8× 193 0.6× 146 1.1× 105 1.3× 28 0.6× 14 401
Zhifan Zeng China 14 371 1.1× 234 0.8× 155 1.2× 41 0.5× 25 0.6× 36 443
D. Avenin France 5 291 0.9× 295 1.0× 221 1.7× 32 0.4× 33 0.7× 9 400
Fitzgibbons Rj United States 5 316 0.9× 181 0.6× 115 0.9× 88 1.1× 69 1.5× 8 403
Charlotte Rees United Kingdom 7 196 0.6× 232 0.8× 138 1.1× 48 0.6× 18 0.4× 9 306
Gordon Cohen United States 8 228 0.7× 240 0.8× 110 0.9× 75 0.9× 109 2.4× 9 365

Countries citing papers authored by N. Malavasi

Since Specialization
Citations

This map shows the geographic impact of N. Malavasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Malavasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Malavasi more than expected).

Fields of papers citing papers by N. Malavasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Malavasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Malavasi. The network helps show where N. Malavasi may publish in the future.

Co-authorship network of co-authors of N. Malavasi

This figure shows the co-authorship network connecting the top 25 collaborators of N. Malavasi. A scholar is included among the top collaborators of N. Malavasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Malavasi. N. Malavasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ferrara, Leonardo, Leonardo Potenza, N. Malavasi, et al.. (2022). Survey on the effectiveness of telephone-based communication with relatives of hospitalized cancer patients in COVID-19 era in Italy. Supportive Care in Cancer. 30(7). 6007–6012. 2 indexed citations
2.
3.
Malavasi, N., et al.. (2011). Diagnostic Delay in Oncology: A Case Report of Metastatic Seminoma. SHILAP Revista de lepidopterología. 4(1). 216–221. 3 indexed citations
4.
Bertolini, Federica, N. Malavasi, Federica Fiocchi, et al.. (2011). FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer. British Journal of Cancer. 104(7). 1079–1084. 31 indexed citations
5.
Bengala, Carmelo, Stefania Bettelli, Federica Bertolini, et al.. (2010). Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. British Journal of Cancer. 103(7). 1019–1024. 36 indexed citations
6.
Fontana, Annalisa, Lorena Losi, Federica Bertolini, et al.. (2010). FOLFOX6 as first-line treatment in metastatic gastric cancer: Preliminary results of a phase II trial.. Journal of Clinical Oncology. 28(15_suppl). 4091–4091. 1 indexed citations
7.
Malavasi, N., Giovanni Ponti, Roberta Depenni, et al.. (2009). Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report. Journal of Hematology & Oncology. 2(1). 35–35. 8 indexed citations
8.
Bengala, Carmelo, Federica Bertolini, N. Malavasi, et al.. (2009). Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial. British Journal of Cancer. 102(1). 68–72. 177 indexed citations
9.
Bengala, Carmelo, Stefania Bettelli, Annalisa Fontana, et al.. (2009). EGFR gene copy number, KRAS and BRAF status, PTEN and AKT expression analysis in patients with metastatic colon cancer treated with anti-EGFR monoclonal antibodies ± chemotherapy. Journal of Clinical Oncology. 27(15_suppl). e15055–e15055. 3 indexed citations
10.
Bengala, Carmelo, Stefania Bettelli, Federica Bertolini, et al.. (2008). Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer. Annals of Oncology. 20(3). 469–474. 72 indexed citations
11.
Bertolini, Federica, Elisabetta De Matteis, N. Malavasi, et al.. (2008). Pulmonary Strongyloidiasis Mimicking Cancer Symptoms. American Journal of Clinical Oncology. 31(3). 308–309. 1 indexed citations
12.
Bertolini, Federica, Silvana Chiara, Carmelo Bengala, et al.. (2008). Neoadjuvant Treatment With Single-Agent Cetuximab Followed by 5-FU, Cetuximab, and Pelvic Radiotherapy: A Phase II Study in Locally Advanced Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 73(2). 466–472. 63 indexed citations
13.
Funaioli, C., Carmine Pinto, Francesco Di Fabio, et al.. (2008). Evaluation of electrolytic imbalance in patients with advanced colorectal and gastric cancer treated with anti-EGFR monoclonal antibody-based therapy. Journal of Clinical Oncology. 26(15_suppl). 14631–14631. 2 indexed citations
14.
15.
Dealis, Cristina, Federica Bertolini, N. Malavasi, et al.. (2008). A phase II trial of sorafenib (SOR) in patients (pts) with advanced cholangiocarcinoma (CC). Journal of Clinical Oncology. 26(15_suppl). 4590–4590. 7 indexed citations
16.
17.
Malavasi, N., Cristina Dealis, Roberta Depenni, et al.. (2007). Phase II trial to evaluate combination of folfox6 + bevacizumab in initially unresectable liver metastases from colorectal cancer (crc). Journal of Clinical Oncology. 25(18_suppl). 14603–14603. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masashi Yahagi Breakdown of academic impact, for papers by Masanori Kotake Breakdown of academic impact, for papers by Linda Evans Breakdown of academic impact, for papers by Fernando Bonadeo Breakdown of academic impact, for papers by D. Mari Breakdown of academic impact, for papers by Zhifan Zeng Breakdown of academic impact, for papers by D. Avenin Breakdown of academic impact, for papers by Fitzgibbons Rj Breakdown of academic impact, for papers by Charlotte Rees Breakdown of academic impact, for papers by Gordon Cohen
Rankless by CCL
2026